217 results
Page 6 of 11
8-K
EX-99.1
qe8tepu 5zs950kgl0
28 Apr 10
Discovery Labs Provides Updates on Surfaxin®, Other Key Programs and First Quarter 2010 Financial Results
12:00am
424B5
qx43u x7oxn5s18yu
28 Apr 10
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
nomw3dmo57x
26 Feb 10
Discovery Labs Announces Completion of
12:00am
424B5
7fasiq
19 Feb 10
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
87615orbj7z30
18 Feb 10
Discovery Labs Prices $16.5 Million Public Offering of
12:00am
424B5
srbsapy gcmouurf
17 Feb 10
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
acmwb7ai4df
4 Dec 09
Discovery Labs Receives Nasdaq Notification Related
12:00am
8-K
EX-99.1
sdl7lw
4 Nov 09
Discovery Labs’ Third Quarter 2009
12:00am
8-K
EX-99.2
xhby3zbsnu3l4dkd qw
4 Nov 09
Discovery Labs’ Third Quarter 2009
12:00am
8-K
EX-99.1
r3fig
30 Sep 09
Discovery Labs and FDA Establish Path for Potential SURFAXIN Approval
12:00am
8-K
EX-99.1
ghsbthidei7tsd928
11 Sep 09
Other Events
12:00am
8-K
EX-10.1
psqthlv734u2d
4 Sep 09
Discovery Labs Announces Date of 2009 Annual Shareholder Meeting
12:00am
8-K
EX-99.1
3dqtq70asf r9su8
4 Sep 09
Discovery Labs Announces Date of 2009 Annual Shareholder Meeting
12:00am
8-K
EX-99.1
n8crc09
19 Aug 09
Discovery Labs Announces Resignation of CEO Robert J. Capetola, Ph.D.; W. Thomas Amick, Chairman of the Board, Appointed Interim CEO
12:00am
8-K
EX-99.1
dphq9
3 Aug 09
Discovery Labs Provides Second Quarter 2009 Financial Results and Business Strategy Update
12:00am